bioAffinity Technologies (BIAF) Preferred Stock Liabilities (2021)
bioAffinity Technologies (BIAF) reported Preferred Stock Liabilities of $4.0 million for Q4 2021.
bioAffinity Technologies (BIAF) Preferred Stock Liabilities (2021) Analysis & Trends
bioAffinity Technologies (BIAF) has 1 years of Preferred Stock Liabilities data on file, last reported at $4.0 million in Q4 2021.
- Preferred Stock Liabilities for Q4 2021 came in at $4.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was $4.0 million (changed N/A YoY), and the FY2021 annual result was $4.0 million, changed N/A from the prior year.
- Preferred Stock Liabilities steadied at $4.0 million in Q4 2021 per BIAF's latest filing.
- Over five years, Preferred Stock Liabilities peaked at $4.0 million in Q4 2021 and troughed at $4.0 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,149.49 Bn | 29,149.03 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 174.37 Bn | 171.12 Bn | 7.74 Bn | - |
| 3 | Danaher | 127.33 Bn | 121.64 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 44.68 Bn | 44.48 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 36.54 Bn | 34.74 Bn | 990.00 Mn | - |
| 6 | Iqvia Holdings | 30.51 Bn | 28.53 Bn | 1.36 Bn | - |
| 7 | Natera | 30.00 Bn | 28.90 Bn | 696.04 Mn | - |
| 8 | Illumina | 24.61 Bn | 23.45 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 22.91 Bn | 22.85 Bn | 555.82 Mn | - |
| 10 | bioAffinity Technologies | 1.98 Mn | -1.12 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 4.04 Mn |